Jennifer A Gross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer A Gross has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Arturo B Ramirez
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Barbara Garvik
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Christian M Loch
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Lance Wells
Complex Carbohydrate Research Center, University of Georgia, Athens, USA
1 shared publication - Martin McIntosh
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
1 shared publication - Nathalie Scholler
Kite Pharma, Santa Monica, CA, USA
1 shared publication
Latest Publications
- Open Access
- 24 July 2008
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 41
Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
Strategies to discover circulating protein markers of ovarian cancer are urgently needed. We developed a novel technology that permits us to isolate recombinant antibodies directed against the potential serum biomarkers, to facilitate the further development of affinity reagents necessary to construct diagnostic tests.
- 24 July 2008
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 41
Open AccessUse of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
Strategies to discover circulating protein markers of ovarian cancer are urgently needed. We developed a novel technology that permits us to isolate recombinant antibodies directed against the potential serum biomarkers, to facilitate the further development of affinity reagents necessary to construct diagnostic tests.